PHILADELPHIA, Sept. 5, 2017 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug ...

Dec. 17, 2003 — Esomeprazole is the most effective proton pump inhibitor (PPI) for gastric acid control, according to the results of a five-way crossover study published in the December issue of the ...

Proton-pump inhibitors (PPIs) are an effective treatment for acid-related conditions, but their efficacy for the treatment of patients with upper gastrointestinal symptoms resulting from nonsteroidal ...

The 20 mg and 40 mg capsules are available in bottle count size of 30 Dr Reddy’s Laboratories (DRL) has launched esomeprazole magnesium delayed-release capsules USP, 20 mg and 40 mg, a therapeutic ...

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg and 40 mg, a therapeutic equivalent generic version of NEXIUM® ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals LLC today announced the launch of its branded Esomeprazole Strontium 49.3 mg delayed-release capsules. Esomeprazole Strontium contains the ...

Hyderabad: Granules India Limited announced that the US Food & Drug Administration (US FDA) has approved its abbreviated new drug application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules ...

Esomeprazole is a proton pump inhibitor that helps reduce the amount of gastric acid produced in the stomach. Image Credit: Sonis Photography / Shutterstock.com Esomeprazole achieves this by ...

TEL-AVIV, Israel and RALEIGH, N.C., Sept. 13, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Esomeprazole (Esoz Fast (40mg)) is a proton pump ...

Esomeprazole is often used to relieve symptoms of gastroesophageal reflux during pregnancy. As there is currently no treatment option available to slow the progression of preeclampsia, clinicians ...

The standard approach to patients with laryngopharyngeal reflux (LPR) is acid-suppressive therapy with proton-pump inhibitors (PPIs). However, studies to support this practice are either uncontrolled ...